Literature DB >> 15815055

Reemergence of staphylococcal toxic shock syndrome in the United States since 2000.

Philip M Tierno.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15815055      PMCID: PMC1081400          DOI: 10.1128/JCM.43.4.2032-2033.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  11 in total

1.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds.

Authors:  Robert S Daum; Teruyo Ito; Keiichi Hiramatsu; Farid Hussain; Kanokporn Mongkolrattanothai; Mantana Jamklang; Susan Boyle-Vavra
Journal:  J Infect Dis       Date:  2002-10-03       Impact factor: 5.226

3.  Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin.

Authors:  P M Schlievert
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

4.  Studies of the staphylococcal causation of toxic shock syndrome.

Authors:  W A Altemeier; S Lewis; P M Schlievert; H S Bjornson
Journal:  Surg Gynecol Obstet       Date:  1981-10

5.  The relationship of tampon characteristics to menstrual toxic shock syndrome.

Authors:  S F Berkley; A W Hightower; C V Broome; A L Reingold
Journal:  JAMA       Date:  1987-08-21       Impact factor: 56.272

6.  Nonmenstrual toxic shock syndrome: a review of 130 cases.

Authors:  A L Reingold; N T Hargrett; B B Dan; K N Shands; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

Authors:  J M Vergeront; S J Stolz; B A Crass; D B Nelson; J P Davis; M S Bergdoll
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

8.  Ecology of toxic shock syndrome: amplification of toxic shock syndrome toxin 1 by materials of medical interest.

Authors:  P M Tierno; B A Hanna
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

9.  Risk factors for staphylococcal toxic-shock syndrome.

Authors:  M W Kehrberg; R H Latham; B T Haslam; A Hightower; M Tanner; J A Jacobson; A G Barbour; V Noble; C B Smith
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

10.  Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro.

Authors:  J Parsonnet; P A Modern; K D Giacobbe
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

View more
  3 in total

1.  Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.

Authors:  Melissa J Karau; Mulualem E Tilahun; Ashton Krogman; Barbara A Osborne; Richard A Goldsby; Chella S David; Jayawant N Mandrekar; Robin Patel; Govindarajan Rajagopalan
Journal:  Virulence       Date:  2016-12-07       Impact factor: 5.882

2.  Prevalence of Staphylococcus aureus strains in an Australian cohort, 1989-2003: evidence for the low prevalence of the toxic shock toxin and Panton-Valentine leukocidin genes.

Authors:  S Schlebusch; J M Schooneveldt; F Huygens; G R Nimmo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-24       Impact factor: 3.267

3.  A study on the microbial quality of sealed products for feminine hygiene.

Authors:  R Briancesco; S Paduano; M Semproni; L Bonadonna
Journal:  J Prev Med Hyg       Date:  2018-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.